Skip to main content
SpringerLink
Log in

Drug Treatment of Epilepsy

Outlines, Criticism and Perspectives

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

This article focuses on important aspects relevant to the assessment of antiepileptic treatment and critically reviews the existing knowledge in this area. The principal variables considered are the commencement of treatment, choice of appropriate drug, efficacy of monotherapy, and cessation of treatment.

When seizure recurrences after the first unprovoked seizure are considered, contradictory data have been provided on the role of early (i.e. after the first seizure) therapy in preventing relapses. The choice of the appropriate drug seems to be dictated more by clinical toxicity than by truly greater efficacy since there is no evidence of significant differences in efficacy among the ‘major’ anticonvulsants such as phenytoin, phenobarbitone, carbamazepine and primidone. Monotherapy is the preferred treatment, at least in previously untreated patients, since up to 90% of cases are completely controlled after variable periods of observation. Cessation of therapy after prolonged seizure control is followed by relapses in a varying percentage of cases depending on several factors, among which is the duration of the period of control. As yet, a definitive comparison of the available information has been prevented by major methodological differences and by partial investigation of the various aspects of the care of the patient with epilepsy.

To provide a tentative answer to some of the open questions concerning the impact of anticonvulsant therapy on the prognosis of the disease, an alternative approach has been proposed, based on the active surveillance of a cohort of newly referred patients started on monotherapy in routine care conditions over a period of more than 5 years. The feasibility of this approach is being tested in a multicentre prospective study currently in progress in Italy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Appendix 1: Controlled Clinical Trials

  • Allen JW, Oxley J, Robertson MM, Trimble MR, Richens A, et al. Clobazam as adjunctive treatment in refractory epilepsy. British Medical Journal 286: 1246–1247, 1983

    PubMed  CAS  Google Scholar 

  • Bensch J, Blennow G, Ferngren H, Gamstorp I, Herrlin KM, et al. A double-blind study of clonazepam in the treatment of therapy-resistent epilepsy in children. Developmental Medicine and Child Neurology 19: 335–342, 1977

    PubMed  CAS  Google Scholar 

  • Cereghino JJ, Brock JT, van Peter JC, Penry JK, Smith LD, et al. Evaluation of albutoin as an antiepileptic drug. Clinical Pharmacology and Therapeutics 15: 406–416, 1974

    PubMed  CAS  Google Scholar 

  • Cereghino JJ, Brock JT, van Peter JC, Penry JK, Smith LD, et al. Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology 29: 401–410, 1974

    Google Scholar 

  • Chandra B. Clonazepam in the treatment of petit mal. Asian Journal of Medicine 9: 433–435, 1973

    Google Scholar 

  • Critchley EMR, Vakil SD, Hayward HW, Owen MVH, Cocks A. et al. Double-blind clinical trial of clobazam in refractory epilepsy. Clobazam: Royal Society of Medicine International Congress and Symposium Series No. 43, pp. 159–163, Academic Press, London, 1981

    Google Scholar 

  • Dam M, Gram L, Philbert A, Hansen BS, Blatt Lyon B, et al.; Progabide: a controlled trial in partial epilepsy. Epilepsia 24: 127–134, 1983

    PubMed  CAS  Google Scholar 

  • Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 2: 71–73, 1982

    PubMed  CAS  Google Scholar 

  • Gibberd FB, Fry DE, Rose FC, Gawel MJ, Page NGR, et al. Comparison of pheneturide and phenytoin. Acta Neurologica Scandinavica 62 (Suppl. 79): 25, 1980

    Google Scholar 

  • Gram L, Rasmussen KE, Flachs H, Wurtz-Jorgensen A, Som-merbeck KB, et al. Valproate sodium: a controlled clinical trial including monitoring of serum levels. Epilepsia 18: 141–148, 1977

    PubMed  CAS  Google Scholar 

  • Green JR, Troupin AS, Halpern LM, Friel P, Kanarek P. Sulthiame: evaluation as an anticonvulsant. Epilepsia 15: 329–349, 1974

    PubMed  CAS  Google Scholar 

  • Killian JM, Fromm GH. A double-blind comparison of nitrazepam versus diazepam in myoclonic seizure disorders. Developmental Medicine and Child Neurology 13: 32–39, 1970

    Google Scholar 

  • Kosteljanetz M, Christiansen J, Mouritzen Dam A, Stensgaard Hansen B, Blatt Lyon B, et al. Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy. Archives of Neurology 36: 22–24, 1979

    PubMed  CAS  Google Scholar 

  • Leppik IE, Derivav AT, Homan RW, Walker J, Ramsay RE, et al. Double-blind study of lorazepam and diazepam in status epilepticus. Journal of the American Medical Association 249: 1452–1454, 1983

    PubMed  CAS  Google Scholar 

  • Loiseau P, Cenraud B, Bossi L, Morselli PL. Double-blind crossover trial with progabide versus placebo in severe epilepsy. In Dam et al. (Eds) Advances in epileptology: XIIth Epilepsy International Symposium, pp. 135–139, Raven Press, New York, 1981

    Google Scholar 

  • Mattson RH, Williamson PD, Hanahan E. Eterobarb therapy in epilepsy. Neurology 26: 1014–1017, 1976

    PubMed  CAS  Google Scholar 

  • Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine 313: 145–151, 1985

    PubMed  CAS  Google Scholar 

  • Mikkelsen B, Berggren P, Joensen P, Kristensen O, Køhler O, et al. Clonazepam (Rivotril) and carbamazepine (Tegretol) in psychomotor epilepsy: a randomized multicenter trial. Epilepsia 22: 415–420, 1981

    PubMed  CAS  Google Scholar 

  • Pryse-Phillips WEM, Jeavons PM. Effect of carbamazepine (Tegretol) on the electroencephalograph and ward behaviour of patients with chronic epilepsy. Epilepsia 11: 263–273, 1970

    PubMed  CAS  Google Scholar 

  • Ramsay RE, Wilder BJ, Berger JR, Bruni J. A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 33: 904–910, 1983

    PubMed  CAS  Google Scholar 

  • Richens A, Ahmad S. Controlled trial of sodium valproate in severe epilepsy. British Medical Journal 4: 255–256, 1975

    PubMed  CAS  Google Scholar 

  • Rodin EA, Rim CS, Rennick PM. The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study. Epilepsia 15: 547–561, 1974

    PubMed  CAS  Google Scholar 

  • Sampliner R, Iber FL. Diphenylhydantoin control of alcohol withdrawal seizures. Journal of the American Medical Association 230: 1430–1432, 1974

    PubMed  CAS  Google Scholar 

  • Sato S, Penry JK, Dreifuss FE, Dyken PR. Clonazepam in the treatment of absence seizures: a double-blind clinical trial. Neurology 27: 371, 1977

    Google Scholar 

  • Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 32: 157–163, 1982

    PubMed  CAS  Google Scholar 

  • Shakir RA, Nanda RN, Lambie DG, Johnson RH. Comparative trial of valproate sodium and clonazepam in chronic epilepsy. Archives of Neurology 36: 301–304, 1979

    PubMed  CAS  Google Scholar 

  • Simonsen N, Zander Olsen P, Kühl V, Lund M, Wendelboe J. A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy. Epilepsia 17: 169–176, 1976

    PubMed  CAS  Google Scholar 

  • Suzuki M, Maruyama H, Ishibashi Y, Ogawa S, Seki T, et al. A double-blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children with special emphasis on pure petit mal seizures. Medical Progress 82: 470–488, 1972

    Google Scholar 

  • Troupin A, Moretti Ojemann L, Halpern L, Dodrill C, Wilkus R, et al. Carbamazepine — a double-blind comparison with phenytoin. Neurology 27: 511–519, 1977

    PubMed  CAS  Google Scholar 

  • Troupin AS, Wilensky AJ, Friel P, Leal K, Ojemann LM. Clorazepate as an anticonvulsant. In Johannessen et al. (Eds) Anti-epileptic therapy: advances in drug monitoring, pp. 291–298, Raven Press, New York, 1980

    Google Scholar 

  • Turner M, Funes JRC, Aspinwall R, Cantlon B, Fejerman N, et al. Ensayo de valoracion clinicoelectroencephalografica de un nuevo derivado benzodiazepinico (Ro 05-4023) administracion oral en pacientes epilepticos con tecnica de doble ceguera. Acta Neurologica Latinoamericana 16: 158–169, 1970

    PubMed  CAS  Google Scholar 

  • van der Linder GJ, Meinardi H, Meijer JWA, Bossi L, Gomeni C. A double-blind crossover trial with progabide (SL 76002) against placebo in patients with secondary generalized epilepsy. In Dam et al. (Eds) Advances in epileptology: Xllth Epilepsy International Symposium, pp. 141–144, Raven Press, New York, 1981

    Google Scholar 

  • Vasella F, Rüdeberg A, Da Silva V, Pavlicova E. Doppelt-blind Untersuchung über die anticonvulsive wirkung von phenobarbital und valproat beim Lennox syndrome. Schweizerische Medizinische Wochenschrift 108: 713–716, 1978

    Google Scholar 

  • Wilensky AJ, Moretti Ojemann L, Temkin NR, Troupin AS, Dodrill CB. Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study. Neurology 31: 1271–1276, 1981 s]Appendix 2: Open Clinical Trials

    PubMed  CAS  Google Scholar 

  • Bang F, Birket-Smith E, Mikkelsen B. Clonazepam in the treatment of epilepsy. A clinical long-term follow-up study. Epilepsia 17: 321–324, 1976

    PubMed  CAS  Google Scholar 

  • Berchou RC, Rodin EA, Russel ME. Clorazepate therapy for refractory seizures. Neurology 31: 1483–1485, 1981

    PubMed  CAS  Google Scholar 

  • Bruni J, Wilder BJ, Bauman AW, Willmore LJ. Clinical efficacy and long-term effects of valproic acid therapy on spike-and-wave discharges. Neurology 30: 42–46, 1980

    PubMed  CAS  Google Scholar 

  • Burin M, Saks G, Gerber BI. Treatment of epilepsy with magnesium dipropylacetate in 81 cases. Semeiotica Medica 140: 678–682, 1972

    Google Scholar 

  • Callaghan N, Kenny RA, O’Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 48: 639–644, 1985

    CAS  Google Scholar 

  • Carson MJ, Gilden C. Treatment of minor motor seizures with clonazepam. Developmental Medicine and Child Neurology 17: 306–310, 1975

    PubMed  CAS  Google Scholar 

  • Chayasirisobhon S, Russell M. Valproic acid and intractable seizures in severely brain-damaged patients. Neurology 33: 99–101, 1983

    PubMed  CAS  Google Scholar 

  • Coulter, DL, Wu H, Allen RJ. Valproic acid therapy in childhood epilepsy. Journal of the American Medical Association 244: 785–788, 1980

    PubMed  CAS  Google Scholar 

  • Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 23: 693–720, 1982

    PubMed  CAS  Google Scholar 

  • Dam M, Christiansen J. Carbamazepine (Tegretol) in the treatment of grand mal epilepsy. In Janz (Ed). Epileptology, pp. 175–179, G. Thieme, Stuttgart, 1976

    Google Scholar 

  • Dam M, Jensen A, Christiansen J. Plasma level and effect of carbamazepine in grand mal and psychomotor epilepsy. Acta Neurologica Scandinavica 60 (Suppl. 75): 33–38, 1975

    PubMed  CAS  Google Scholar 

  • Dumermuth G, Kovacs E. The effect of clonazepam (Ro 5-4023) in the syndrome of infantile spasms with hypsarrhythmia and in petit mal variant or Lennox syndrome. Acta Neurologica Scandinavica 49 (Suppl. 53): 26–28, 1973

    Google Scholar 

  • Fazio C, Manfredi M, Piccinelli A. Treatment of epileptic seizures with clonazepam. Archives of Neurology 32: 304–307, 1975

    PubMed  CAS  Google Scholar 

  • Fichsel H, Heyer R. Carbamazepine in the treatment of epilepsy in children. Deutsche Medizinische Wochenschrift 95: 2367–2374, 1970

    PubMed  CAS  Google Scholar 

  • Gastaut H. The effect of benzodiazepines on chronic epilepsy in man (with particular reference to clobazam). In Clobazam: Royal Society of Medicine International Congress and Symposium Series No. 43, pp. 141–150, Academic Press, London, 1981

    Google Scholar 

  • Gastaut H, Low MD. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man. Epilepsia 20: 437–446, 1979

    PubMed  CAS  Google Scholar 

  • Haf R, Schain RJ. Long-term experiences with carbamazepine (Tegretol) in children with seizures. Annals of Neurology 2: 258, 1977

    Google Scholar 

  • Harding GFA, Herrick CE, Jeavons PM. A controlled study of the effect of sodium valproate on photosensitive epilepsy and its prognosis. Epilepsia 19: 555–565, 1978

    PubMed  CAS  Google Scholar 

  • Hassan MN, Laljee HCK, Parsonage MJ. Sodium valproate in the treatment of resistant epilepsy. Acta Neurologica Scandinavica 54: 209–218, 1976

    PubMed  CAS  Google Scholar 

  • Hassan MN, Parsonage MJ. Experience in the long-term use of carbamazepine (Tegretol) in the treatment of epilepsy. In Penry (Ed.) Epilepsy. The Eighth International Symposium, pp. 35–44, Raven Press, New York, 1977

    Google Scholar 

  • Henriksen O, Johannessen SI. Clinical and pharmacokinetic observations on sodium valproate: a five-year follow-up study in 100 children with epilepsy. Epilepsia 23: 435–436, 1982

    Google Scholar 

  • Huang CY, McLeod JG, Sampson D, Hensley WJ. Clonazepam in the treatment of epilepsy. Medical Journal of Australia 2: 5–8, 1974

    PubMed  CAS  Google Scholar 

  • Jeavons PM, Clark JE. Sodium valproate in treatment of epilepsy. British Medical Journal 2: 584–586, 1974

    PubMed  CAS  Google Scholar 

  • Jeavons PM, Clark JE, Maheshwari MC. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (‘Epilim’). Developmental and Child Neurology 19: 9–25, 1977

    CAS  Google Scholar 

  • Lance JW, Anthony M. Sodium valproate and clonazepam in the treatment of intractable epilepsy. Archives of Neurology 34: 14–17, 1977

    PubMed  CAS  Google Scholar 

  • Lehtovaara R. A clinical trial with clonazepam (Ro 5-4023). Acta Neurologica Scandinavica 49 (Suppl. 53): 77–81, 1973

    Google Scholar 

  • Lerman P, Kivity-Ephraim S. Carbamazepine sole anticonvulsant for focal epilepsy of childhood. Epilepsia 15: 229–234, 1974

    PubMed  CAS  Google Scholar 

  • Lerman P, Nussbaum E. The use of sulthiame in myoclonic epilepsy of childhood and adolescence. Acta Neurologica Scandinavica 60 (Suppl. 75): 7–12, 1975

    PubMed  CAS  Google Scholar 

  • Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma level. Archives of Neurology 31: 289–294, 1974

    PubMed  CAS  Google Scholar 

  • Lund M, Trolle E. Clonazepam in the treatment of epilepsy. Acta Neurologica Scandinavica 49 (Suppl. 53): 82–90, 1973

    Google Scholar 

  • Martin AA. The anti-epileptic effects of clobazam: a long-term study in resistant epilepsy. In Clobazam: Royal Society of Medicine International Congress and Symposium Series No. 43, pp. 151–157, Academic Press, London, 1981

    Google Scholar 

  • Mikkelsen B, Birket-Smith E. A clinical study of the benzodiazepine Ro 5-4023 (clonazepam) in the treatment of epilepsy. Acta Neurologica Scandinavica 49 (Suppl. 53): 90–91, 1973

    Google Scholar 

  • Monaco F, Riccio A, Fantini M, Baruzzi A, Morselli PL. A month-by-month long-term study on carbamazepine: clinical, EEG and pharmacological evaluation. Journal of International Medical Research 7: 152–157, 1979

    PubMed  CAS  Google Scholar 

  • Munthe-Kass AW, Strandjord RE. Clonazepam in the treatment of epileptic seizures. Acta Neurologica Scandinavica 49 (Suppl. 53): 97–102, 1973

    Google Scholar 

  • Nanda RN, Johnson RH, Keogh HJ, Lambie DG, Melville ID, et al. Treatment of chronic epilepsy for 1 to 2 years with clonazepam. In Penry (Ed). Epilepsy. The Eighth International Symposium, pp. 163–168, Raven Press, New York, 1977

    Google Scholar 

  • O’Donohoe NV, Paes BA. A trial of clonazepam in the treatment of severe epilepsy in infancy and childhood. In Penry (Ed). Epilepsy. The Eighth International Symposium, pp. 159–162, Raven Press, New York, 1977

    Google Scholar 

  • Rodin EA, Choon Soo R, Kitano H, Lewis R, Rennick PM. A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. Journal of Nervous and Mental Disease 163: 41–46, 1976

    PubMed  CAS  Google Scholar 

  • Scheffner D, Schiefer I. The treatment of epileptic children with carbamazepine. Follow-up studies of clinical course and EEG. Epilepsia 13: 819–828, 1972

    PubMed  CAS  Google Scholar 

  • Scollo-Lavizzari G, Pralle W, de la Cruz N. Clinical experience with clonazepam (Rivotril) in the treatment of epilepsy in adults. European Neurology 11: 340–344, 1974

    PubMed  CAS  Google Scholar 

  • Shakir RA, Johnson RH, Lambie DG, Melville ID, Nanda RN. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia 22: 27–33, 1981

    PubMed  CAS  Google Scholar 

  • Sherard Jr ES, Steiman GS, Couri D. Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial. Neurology 30: 31–35, 1980

    PubMed  Google Scholar 

  • Shorvon SD, Reynolds EH. Early prognosis of epilepsy. British Medical Journal 285: 1699–1701, 1982

    PubMed  CAS  Google Scholar 

  • Sillanpää M, Donner M. Experiences on the use of dipropylacetate in the treatment of childhood epilepsy. Acta Paediatrica Scandinavica 65: 209–215, 1976

    PubMed  Google Scholar 

  • Sillanpää M, Pynnönen S, Laippala P, Säkö E. Carbamazepine in the treatment of partial epileptic seizures in infants and young children: a preliminary study. Epilepsia 20: 563–569, 1979

    PubMed  Google Scholar 

  • Sing AN, Saxena BM, Germain M. Anticonvulsive and psychotropic effects of carbamazepine in hospitalized epileptic patients: a long-term study. In Penry (Ed). Epilepsy: Eighth International Symposium, pp. 47–56, Raven Press, New York, 1977

    Google Scholar 

  • Strandjord RE, Johannessen SI. Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect. Epilepsia 21: 655–662, 1980

    PubMed  CAS  Google Scholar 

  • Völzke E, Doose H. Dipropylacetate (Dépakine, Ergenyl) in the treatment of epilepsy. Epilepsia 14: 185–193, 1973

    PubMed  Google Scholar 

  • Wilder BJ, Ramsay RE, Murphy JV, Karas BJ, Marquardt K, et al. Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology 33: 1474–1476, 1983 l]References

    PubMed  CAS  Google Scholar 

  • Abild K, Dam M. Practical aspects in the treatment of epilepsy. Acta Neurologica Scandinavica 68 (Suppl. 97): 29–40, 1983

    Google Scholar 

  • Beghi E, Sasanelli F, Spagnoli A, Tognoni G. Quality of care of epilepsy in Italy: a multi-hospital survey of diagnosis and treatment of 1104 epileptic patients. Epilepsia 23: 133–148, 1982

    PubMed  CAS  Google Scholar 

  • Blom S, Heijbel J, Bergfors PG. Incidence of epilepsy in children: a follow-up study three years after the first seizure. Epilepsia 19: 343–350, 1978

    PubMed  CAS  Google Scholar 

  • Callaghan N, O’Callaghan M, Duggan B, Feely M. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. Journal of Neurology, Neurosurgery and Psychiatry 41: 907–912, 1978

    CAS  Google Scholar 

  • Cawthorne IF, Silas JH. Impact of therapeutic audit on phenytoin prescribing. British Medical Journal 282: 1278 (1981)

    PubMed  CAS  Google Scholar 

  • Cleland PG, Mosquera I, Steward WP, Foster JB. Prognosis of isolated seizures in adult life. British Medical Journal 283: 1364, 1981

    PubMed  CAS  Google Scholar 

  • Coatsworth JJ, Penry JK. Clinical efficacy and use. In Woodbury et al. (Eds) Antiepileptic drugs, pp. 87–96, Raven Press, New York, 1972

    Google Scholar 

  • Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 23: 693–720, 1982

    PubMed  CAS  Google Scholar 

  • Dreifuss FE. Use of anticonvulsant drugs. Journal of the American Medical Association 241: 607–609, 1979

    PubMed  CAS  Google Scholar 

  • Eadie MJ. Which anticonvulsant drug? Drugs 17: 213–218, 1979

    PubMed  CAS  Google Scholar 

  • Elwes RDC, Chesterman P, Reynolds EH. Prognosis after a first untreated tonic-clonic seizure. Lancet 2: 752–753, 1985

    PubMed  CAS  Google Scholar 

  • Emerson R, D’Souza BJ, Vining EP, Holden KR, Mellits ED. et al. Stopping medication in children with epilepsy. Predictors of outcome. New England Journal of Medicine 304: 1125–1129, 1981

    PubMed  CAS  Google Scholar 

  • Feely M, O’Callaghan M, Duggan B, Callaghan N. Phenobarbitone in previously untreated epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 43: 356–368, 1980

    Google Scholar 

  • Fukuyama Y, Arima M, Nagahata M, Okada R. Medical treatment of epilepsies in childhood. A long-term survey of 801 patients. Epilepsia 4: 207–224, 1963

    PubMed  CAS  Google Scholar 

  • Glaser GH, Penry JK, Woodbury DM (Eds). Antiepileptic drugs: mechanisms of action, Raven Press, New York, 1980

    Google Scholar 

  • Gowers WR. Epilepsy and other chronic convulsive disorders, Churchill, Edinburgh, 1881

    Google Scholar 

  • Gram L, Drachmann Bentsen K, Parnas J, Flachs H. Controlled trials in epilepsy: a review. Epilepsia 23: 491–519, 1982

    PubMed  CAS  Google Scholar 

  • Guelen PJM, Johannessen SI. Prescription pattern of antiepileptic drugs to epileptic patients: a comparison between the Netherlands and Norway. In Gardner-Thorpe (Ed). Antiepileptic drug monitoring, pp. 345–350, Pitman, Tunbridge Wells, 1977

    Google Scholar 

  • Hauser WA, Elving Anderson V, Loewenson RB, McRobertson SM. Seizure recurrence after a first unprovoked seizure. New England Journal of Medicine 307: 522–528, 1982

    PubMed  CAS  Google Scholar 

  • Hirtz DG, Ellenberg JH, Nelson KB. The risk of recurrence of nonfebrile seizures in children. Neurology 34: 637–641, 1984

    PubMed  CAS  Google Scholar 

  • Holowach J, Thurston DL, O’Leary J. Prognosis in childhood epilepsy. Follow-up study of 148 cases in which therapy had been suspended after prolonged anticonvulsant control. New England Journal of Medicine 286: 169–174, 1972

    PubMed  CAS  Google Scholar 

  • Holowach-Thurston J, Thurston DL, Hixon BB, Keller AJ. Prognosis in childhood epilepsy. Additional follow-up of 148 children 15 to 23 years after withdrawal of anticonvulsant therapy. New England Journal of Medicine 306: 831–836, 1982

    Google Scholar 

  • Hopkins A, Scambler G. How doctors deal with epilepsy. Lancet 2: 183–186, 1977

    Google Scholar 

  • Jeavons PM. Choice of drug therapy in epilepsy. Practitioner 219: 542–556, 1977

    PubMed  CAS  Google Scholar 

  • Johnson LC, LeBolt WL, Long MT, Ross JJ, Sassin JF, et al. Diagnostic factors in adult males following initial seizures. Archives of Neurology 27: 193–197, 1972

    PubMed  CAS  Google Scholar 

  • Juul-Jensen P. A clinical and social analysis of 1020 adult patients with epileptic seizures. Acta Neurologica Scandinavica 40 (Suppl. 5), 1964

    Google Scholar 

  • Juul-Jensen P. Frequency of recurrence after discontinuance of anticonvulsant therapy in patients with epileptic seizures. A new follow-up study after 5 years. Epilepsia 9: 11–16, 1968

    PubMed  CAS  Google Scholar 

  • Krall RL, Penry JK, Kupferberg HJ, Swinyard EA. Antiepileptic drug development: I. History and a program for progress. Epilepsia 19: 393–408, 1978

    PubMed  CAS  Google Scholar 

  • Livingston S. Convulsive disorders in infants and children. Advances in Pediatrics 10: 113–195, 1958

    Google Scholar 

  • Livingston S. Medical treatment of epilepsy, part I. Southern Medical Journal 71: 298–310. 1978

    PubMed  CAS  Google Scholar 

  • Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. Archives of Neurology 31: 289–294, 1974

    PubMed  CAS  Google Scholar 

  • Meinardi H, Magnus O. Drug therapy. Clinical application. In Magnus & Lorentz De Haas (Eds) The epilepsies, pp. 664–672, North Holland, Amsterdam, 1974

    Google Scholar 

  • Meinardi H, van Heycop ten Ham MW, Meijer JWA, Bongers E. Long-term control of seizures. In Penry (Ed.) Epilepsy: Eighth International Symposium, pp. 17–26, Raven Press, New York, 1977

    Google Scholar 

  • Milano Collaborative Group for Studies on Epilepsy. Long-term intensive monitoring in the difficult patient. Preliminary results of 16 months of observations — usefulness and limitations. In Gardner-Thorpe (Ed.) Antiepileptic drug monitoring, pp. 197–213, Pitman, Tunbridge Wells, 1977

    Google Scholar 

  • Oller-Daurella L, Oiler F-V, Pamies R. Clinical, therapeutic and social status of epileptic patients without seizures for more than five years. In Penry (Ed). Epilepsy: Eighth International Symposium, pp. 69–75, Raven Press, New York, 1977

    Google Scholar 

  • Oller-Daurella L, Oller FVL, Sanchez ME. Discontinuance of antiepileptic therapy in epileptics seizure-free for more than five years. Acta Neurologica Scandinavica 62 (Suppl.) 79: 81, 1980

    Google Scholar 

  • Penry JK, Newmark ME. The use of antiepileptic drugs. Annals of Internal Medicine 90: 207–218, 1979

    PubMed  CAS  Google Scholar 

  • Porter RJ, Penry JK. Efficacy and choice of antiepileptic drugs. In Meinardi & Rowan (Eds) Advances in epileptology, pp. 220–230, Swets & Zeitlinger, Amsterdam, 1978

    Google Scholar 

  • Reynolds EH, Chadwick D, Galbraith AW. One drug (phenytoin) in the treatment of epilepsy. Lancet 1: 923–926, 1976

    PubMed  CAS  Google Scholar 

  • Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia 22: 1–10, 1981

    PubMed  CAS  Google Scholar 

  • Reynolds EH, Shorvon SD, Galbraith AW, Chadwick D, Dellaportas CI et al. Phenytoin monotherapy for epilepsy: a long-term prospective study, assisted by serum levels monitoring, in previous untreated patients. Epilepsia 22: 475–488, 1981

    PubMed  CAS  Google Scholar 

  • Richens A. Clinical pharmacology and medical treatment. In Laidlaw & Richens (Eds) A textbook of epilepsy, pp. 185–247, Churchill Livingstone, Edinburgh, 1976

    Google Scholar 

  • Rodin EA. Medical and social prognosis in epilepsy. Epilepsia 13: 121–131, 1972

    PubMed  CAS  Google Scholar 

  • Schmidt D. One drug treatment with phenytoin in difficult-to-treat epilepsies with complex partial seizures: a preliminary report of a prospective study. In Johannessen et al. (Eds) Antiepileptic therapy: advances in drug monitoring, pp. 221–228, Raven Press, New York, 1980

    Google Scholar 

  • Shakir RA, Johnson RH, Lambie DG, Melville ID, Nanda RN. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia 22: 27–33, 1981

    PubMed  CAS  Google Scholar 

  • Shinnar S, Vining EPG, Mellits ED, D’Souza BJ, Holden K, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizures: a prospective study. New England Journal of Medicine 313: 976–980, 1985

    PubMed  CAS  Google Scholar 

  • Shorvon SD, Chadwick D, Galbraith AW, Reynolds AW, Reynolds EH. One drug for epilepsy. British Medical Journal 1: 474–476, 1978

    PubMed  CAS  Google Scholar 

  • Shorvon SD, Reynolds EH. Unnecessary polypharmacy for epilepsy. British Medical Journal 1: 1635–1637, 1977

    PubMed  CAS  Google Scholar 

  • Shorvon SD, Reynolds EH. Early prognosis of epilepsy. British Medical Journal 285: 1699–1701, 1982

    PubMed  CAS  Google Scholar 

  • Strandjord RE, Johannessen SI. Carbamazepine as the only drug in patients with epilepsy: Serum levels and clinical effects. In Johannessen et al. (Eds) Antiepileptic therapy: advances in drug monitoring, pp. 229–235, Raven Press, New York, 1980

    Google Scholar 

  • Sutherland JM, Eadie MJ. The epilepsies: modern diagnosis and treatment, 3rd ed, pp. 99–103, Churchill Livingstone, New York, 1980

    Google Scholar 

  • Thomas MH. The single seizure — its study and management. Journal of the American Medical Association 169: 457–459, 1959

    PubMed  CAS  Google Scholar 

  • Todt H. The late prognosis of epilepsy in childhood: results of a prospective follow-up study. Epilepsia 25: 137–144, 1984

    PubMed  CAS  Google Scholar 

  • Troupin AS. The choice of anticonvulsants. In Proceedings of the 25th Western Institute on Epilepsy, Las Vegas, Nevada, March 26, 1975

  • Williams D. The Border-land of epilepsy revisited. Brain 98: 1–12, 1975

    PubMed  CAS  Google Scholar 

  • Woodbury DM, Penry JK, Pippenger CE (Eds). Antiepileptic drugs, Raven Press, New York, 1982

    Google Scholar 

  • Yahr MD, Sciarra D, Carter S, Merritt HH. Evaluation of standard anticonvulsant therapy in three hundred nineteen patients. Journal of the American Medical Association 150: 663–667, 1952

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical Pharmacology, ‘Mario Negri’ Institute for Pharmacological Research, Via Eritrea 62, 20157, Milano, Italy

    Ettore Beghi, Rocco Di Mascio & Gianni Tognoni

Authors
  1. Ettore Beghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rocco Di Mascio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gianni Tognoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beghi, E., Di Mascio, R. & Tognoni, G. Drug Treatment of Epilepsy. Drugs 31, 249–265 (1986). https://doi.org/10.2165/00003495-198631030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198631030-00003

Keywords

Search

Navigation